Call for Chapters: Exploring the Efficacy and Beneficence of Complementary and Alternative Medicinal Products in Disease Therapy

Editors

ETETOR ROLAND ESHIET

Call for Chapters

Proposals Submission Deadline: August 17, 2020
Full Chapters Due: September 28, 2020

Introduction

Recent breakthroughs in science and technology have led to a concomitant growth in exploratory studies into the definitive properties of traditional therapies employed in medicine and pharmacology. Complementary and Alternative Medicine (CAM) involves a diverse range of medicinal and health practices and products that are typically not part of conventional medicine. Presently, there are a multitude of research studies investigating the promise and potential of CAM products in disease therapy. This book aspires to be a compendium of recent results highlighting topical pre-clinical (in vitro, in vivo) and clinical trial studies undertaking this effort. A record of concentric investigations into the therapeutic properties of particular products may assure researchers and the public of safety, efficacy and beneficent implications. It is the intention of the editor to solicit and corral scientific findings that establish a continuum of research investigations exhibiting the enormous possibilities of CAM and the financial benefits thereof; it is the prerogative of the editor to tie together book chapters that ultimately present a holistic overview, and make an intelligent argument for an aggressive, sustained research into the capabilities of CAM in disease therapy applications.

Objective

The primary objective of this book is to illustrate, or rather demonstrate, one or more instances where a continuum of research findings on certain CAM products are indicative of the potential CAM has in the treatment of a plethora of diseases and comorbidities. The editor aspires to articulate the correlation between determinations obtained from pre-clinical and clinical research programs; qualitative and quantitative analysis of datasets generated from experimentation outlined in each book chapter shall constitute valid indicators of the efficacy of CAM in contemporary medical practice. Furthermore, an accurate delineation of the cost implications of using CAM products compared to current orthodox practice will be discussed in detail.

Target Audience

The target audience for this book includes but is not limited to the following: 1) Pharmaceutical companies; 2) Clinical Research Organization's (CROs); 3) Universities and Colleges: academic staff and students; 4) Healthcare providers (medical practitioners etc.); 5) Medical, healthcare, and life sciences community; 6) Researchers; 7) Scientists; 8) Public Health workers etc. The editor of this book hopes that it will be one of many instruments used to make a coordinated, concerted argument for the increased utilization of CAM in disease therapy; the editor ambitiously expects that this book assures researchers and the public of safety, efficacy, beneficent and cost implications of employing CAM in patient care.

Recommended Topics

Contributing authors are invited to submit research findings in pre-clinical (in vitro, in vivo), clinical
trial, and cost analysis studies.

The book shall be comprised of: five (5) book chapters on in vitro studies; five (5) book chapters
on in vivo studies; five (5) book chapters on clinical trial programs; and two (2) book chapters
focused on the examination and evaluation of the comparative cost implications of CAM in present
day society.

Submissions made shall fall within the primary (suggested) areas of CAM: a) biologically based
practices; b) whole medical systems; c) manipulative and body based practices; and d) mind-body medicine.

The topics in the book shall be listed as follows:
1) Epigraph
2) Preface
3-7) Book chapters on in vitro studies
8-12) Book chapters on in vivo studies
13-17) Book chapters on clinical trial studies
18) Perspective of a healthcare professional discussing the cost implications (cost analysis) of
using CAM products and practice vi-a-vis contemporary pharmaceuticals and clinical
practice
19) Perspective of a healthcare professional examining the current scope and quality of CAM
economic evaluations
20) Discussion
21) Conclusion
22) Compilation of References
23) Index
Note: The structure of the table of contents as it stands is tentative. As submissions are received,
on subjects of particular interest, a more definitive sequence will be developed.


Submission Procedure

Researchers and practitioners are invited to submit on or before August 17, 2020 , a book chapter proposal on studies that speak to the premise of the book and are within the major groups of CAM. Each submission shall comprise of 1,000 to 2,000 words clearly explaining the hypotheses made and results obtained. Authors will be notified by August 31, 2020 about the status of their proposals and sent chapter guidelines. Full chapters are expected to be submitted by September 28, 2020 and all interested authors must consult the guidelines for manuscript submissions at http://www.igi-global.com/publish/contributor-resources/before-you-write/ prior to submission. All submitted chapters will be reviewed on a double-blind review basis. Contributors may also be requested to serve as reviewers for this project.
Researchers who have performed in vitro, in vivo (pre-clinical) and clinical trial studies involving the use of CAM products are invited to submit book chapters discussing their findings within the parameters of the book's objectives. Healthcare professionals who have performed studies that CAM in present day society are also encouraged to make submissions. We welcome both original research articles and review articles.
Note: There are no submission or acceptance fees for manuscripts submitted to this publication, Exploring the Efficacy and Beneficence of Complementary and Alternative Medicinal Products i Disease Therapy. All manuscripts are accepted based on a double-blind peer review editorial process.
All proposals should be submitted through the eEditorial Discovery®TM online submission manager.


Publisher

This book is scheduled to be published by IGI Global (formerly Idea Group Inc.), an international academic publisher of the "Information Science Reference" (formerly Idea Group Reference), "Medical Information Science Reference," "Business Science Reference," and "Engineering Science Reference" imprints. IGI Global specializes in publishing reference books, scholarly journals, and electronic databases featuring academic research on a variety of innovative topic areas including but not limited to education, social science, medicine and healthcare, business and management, information science and technology, engineering, public administration, library and information science, media and communication studies, and environmental science. For additional information regarding the publisher, please visitwww.igi-global.comm. This publication is anticipated for release in 2021.

Important Dates

1st Proposal Submission: August 24, 2020
Full Chapter Submission: September 28, 2020
Reviews due to Authors: October 30, 2020, 2020
Revision due from Authors: November 30, 2020


Inquiries

Etetor Roland Eshiet, Ph.D.
Editor
Exploring the Efficacy and Beneficence of Complementary and Alternative Medicinal Products in
Disease Therapy
Email: etetoreshiet@yahoo.com, etetor.eshiet@see-ed.com


Back to Call for Papers List